News
-
-
PRESS RELEASE
FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team
FSD Pharma's Celly Nutrition launches unbuzzd™, a new beverage aiding alcohol metabolism. Featuring innovative stick packs, it supports faster recovery and enhanced cognition -
-
-
-
PRESS RELEASE
FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd.
FSD Pharma Inc. announces victory in legal battle against Dr. Raza Bokhari. Court judgment grants FSD Pharma damages and interest. Future plans detailed -
-
PRESS RELEASE
FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia
FSD Pharma announces HREC approval for Lucid-21-302 trial in Australia. Lucid-21-302 is a neuroprotective compound for multiple sclerosis treatment -
-
PRESS RELEASE
FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications
FSD Pharma Inc. enters into an exclusive option agreement with the University of Southern California to evaluate dietary supplement technology for commercialization, potentially enhancing unbuzzd™ effectiveness and expanding target markets with novel products
